However, emerging evidence suggests that MAP4K4 may also act as a tumor suppressor in PDAC, where its depletion leads to enhanced tumor progression via hyperactivation of the AKT, ERK and mTORC signaling pathways. Here, MAPK1 is linked to neoplasm.